Kefu Medical: Net profit attributable to parent company in 2025 is expected to increase by 19.2% to 372 million yuan, strengthening market competitiveness of high-end home health monitoring products

2026-03-10 13:46:40

Abstract generation in progress

Recently, Kefu Medical announced its 2025 annual report. The company’s operating revenue was 3.39 billion yuan, an increase of 13.6% year-over-year; net profit attributable to shareholders was 372 million yuan, up 19.2%; net profit after deducting non-recurring gains and losses was 298 million yuan, up 8.3%; net operating cash flow was 696 million yuan, a 4.9% increase; and EPS (fully diluted) was 1.7789 yuan.

The annual report mentioned that there were no significant changes in its business operations. The company continues to focus on the research, production, and sales of medical devices, committed to providing comprehensive personal health management solutions throughout the entire lifecycle. The report shows that the company’s product lines are continuously expanding across multiple fields, including health monitoring, rehabilitation aids, and respiratory support, with ongoing efforts in technological innovation and meeting market demands.

Additionally, the company has strengthened collaborations with international brands, especially through strategic cooperation with Royal Philips, aiming to enhance the market competitiveness of high-end home health monitoring products. The company’s efforts in digital transformation and intelligent manufacturing are also ongoing to improve production efficiency and product quality.

(Kefu Medical Announcement)

(Edited by: Yang Yan, Lin Chen)

Keywords: Healthcare

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.